1. Home
  2. CTS vs BCRX Comparison

CTS vs BCRX Comparison

Compare CTS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

N/A

Current Price

$61.31

Market Cap

1.8B

Sector

Technology

ML Signal

N/A

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$7.65

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTS
BCRX
Founded
1896
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
CTS
BCRX
Price
$61.31
$7.65
Analyst Decision
Buy
Buy
Analyst Count
2
11
Target Price
★ $73.67
$20.45
AVG Volume (30 Days)
216.6K
★ 5.6M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
★ 0.26%
N/A
EPS Growth
15.87
★ 381.40
EPS
★ 1.87
N/A
Revenue
★ $541,318,000.00
$25,186,000.00
Revenue This Year
$7.20
N/A
Revenue Next Year
$7.57
$3.71
P/E Ratio
$33.41
★ N/A
Revenue Growth
★ 4.95
N/A
52 Week Low
$40.15
$6.23
52 Week High
$69.55
$11.22

Technical Indicators

Market Signals
Indicator
CTS
BCRX
Relative Strength Index (RSI) 55.83 43.24
Support Level $55.42 $7.62
Resistance Level $63.34 $8.83
Average True Range (ATR) 2.44 0.39
MACD 0.25 -0.03
Stochastic Oscillator 70.15 23.55

Price Performance

Historical Comparison
CTS
BCRX

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: